Genotoxicity of nano- and micron-sized manganese oxide in rats after acute oral treatment

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 754, Issue 1-2, 2013, Pages 39-50

  Singh, Shailendra Pratap ^a   Kumari, Monika ^a   Kumari, Srinivas I ^a   Rahman, Mohammed F ^a   Kamal, S S Kalyan ^b   Mahboob, M ^a   Grover, Paramjit ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b DEFENCE METALLURGICAL RESEARCH LABORATORY   (India)

Author keywords

Biochemical parameters; Biodistribution; Genotoxicity; MnO2 45nm; MnO2 bulk; Wistar rats

Indexed keywords

ACETYLCHOLINESTERASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; MAGNESIUM; MANGANESE OXIDE; NANOPARTICLE; POTASSIUM; SODIUM;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; BIOCHEMISTRY; BONE MARROW CELL; BRAIN LEVEL; CHROMOSOME ABERRATION; COMET ASSAY; DNA DAMAGE; ENZYME ACTIVITY; ERYTHROCYTE; FECES ANALYSIS; FEMALE; GENOTOXICITY; HISTOPATHOLOGY; LASER DOPPLER FLOWMETRY; LEUKOCYTE; LIVER; MICRONUCLEUS TEST; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; URINALYSIS;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CHROMOSOME ABERRATIONS; COMET ASSAY; FEEDING BEHAVIOR; FEMALE; MANGANESE COMPOUNDS; MICRONUCLEUS TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; ORGAN SIZE; OXIDES; PARTICLE SIZE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84878516059     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.04.003     Document Type: Article

References (46)

1. Arora S., Rajwade J.M., Paknikar K.M. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol. 2012, 258:151-165.
2. Na H.B., Lee J.H., An K., Park Y.I., Park M., Lee I.S., Nam D.H., Kim S.T., Kim S.H., Kim S.W., Lim K.H., Kim K.S., Kim S.O., Hyeon T. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem. Int. Ed. 2007, 46:5397-5401.
3. Shin J., Rahman Md.A., Ko M.K., Im G.H., Lee J.H., Lee I.S. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew. Chem. Int. Ed. 2009, 48:321-324.
4. Taira S., Kitajima K., Katayangi H., Ichiishi E., Ichiyanagi Y. Manganese oxide nanoparticle assisted laser desorption/ionization mass spectrometry for medical application. Sci. Technol. Adv. Mater. 2009, 10:1-6.
5. Chen H., He J. Facile synthesis of monodisperse manganese oxide nanostructures and their application in water treatment. J. Phys. Chem. C 2008, 112:17540-17545.
6. Rutz A. Synthesis and properties of manganese oxide nanoparticles for environmental applications. The 2009 NNIN REU Research Accomplishments 2009, 98-99.
7. Stefanescu D.M., Khoshnan A., Patterson P.H., Hering J.G. Neurotoxicity of manganese oxide nanomaterials. J. Nanopart. Res. 2009, 11:1957-1969.
8. Nagwa H.A., Kanthasamy A., Gu Y., Fang N., Anantharam V., Kanthasamy A.G. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicol. Appl. Pharmacol. 2011, 256:227-240.
9. Wang J., Rahman M.F., Duhart H.M., Newport G.D., Patterson T.A., Murdock R.M. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30:926-933.
10. Frick R., Müller-Edenborn B., Schlicker A., Rothen-Rutishauser B., Raemy D.O., Günther D., Hattendorf B., Stark W., Beck-Schimmer B. Comparison of manganese oxide nanoparticles and manganese sulfate with regard to oxidative stress, uptake and apoptosis in alveolar epithelial cells. Toxicol. Lett. 2011, 205:163-172.
11. Choi J.Y., Lee S.H., Na H.B., An K., Hyeon T., Seo T.S. In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines. Bioprocess Biosyst. Eng. 2010, 33:21-30.
12. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19:975-983.
13. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 2006, 92:456-463.
14. Sarkozi L., Horvath E., Konya Z., Kiricsi I., Szalay B., Vezer T., Papp A. Subacute intratracheal exposure of rats to manganese nanoparticles: behavioral, electrophysiological, and general toxicological effects. Inhal. Toxicol. 2009, 21:83-91.
15. Oszlanczi G., Vezer T., Sarkozi L., Horvath E., Szabo A., Horvath E., Konya Z., Papp A. Metal deposition and functional neurotoxicity in rats after 3-6 weeks nasal exposure by two physicochemical forms of manganese. Ecotoxicol. Environ. Saf. 2010, 30:121-126.
16. Oszlanczi G., Vezer T., Sarkozi L., Horvath E., Konya Z., Papp A. functional neurotoxicity of Mn-containing nanoparticles in rats. Ecotoxicol. Environ. Saf. 2010, 73:2004-2009.
17. Fischer H.C., Chan W.C.W. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 2007, 18:565-571.
18. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
19. Murdock R.C., Braydich-Stolle L., Schrand A.M., Schlager J.J., Hussain S.M. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol. Sci. 2008, 101:239-253.
20. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. The single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
21. Baek M., Chung H.E., Yu J., Lee J.A., Paek S.M., Lee J.K., Jeong J., Choy J.H., Choi S.J. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int. J. Nanomed. 2012, 7:3081-3097.
22. Umbreit T.H., Francke-Carroll S., Weaver J.L., Miller T.J., Goering P.L., Sadrieh N., Stratmeyer M.E. Tissue distribution and histopathological effects of titanium dioxide nanoparticles after intravenous or subcutaneous injection in mice. J. Appl. Toxicol. 2012, 32:350-357.
23. OECD Guidelines 420 Acute oral toxicity - fixed dose procedure (2001).
24. Schmid W. The micronucleus test. Mutat. Res. 1975, 31:9-15.
25. OECD Guidelines 474 genetic toxicology: micronucleus test (1997).
26. Adler I.D. Cytogenetic tests in mammals. Mutagenicity Testing: A Practical Approach 1984, 273-306. IRL Press, Oxford. S. Venitt, J. Parry (Eds.).
27. OECD Guidelines 475 genetic toxicology: in vivo mammalian bone marrow cytogenetic test-chromosome analysis (1997).
28. Kumari M., Rajak S., Singh S.P., Kumari S.I., Kumar P.U., Murty U.S.N., Mahboob M., Grover P., Rahman M.F. Repeated oral dose toxicity of iron oxide nanoparticles: biochemical and histopathological alterations in different tissues of rats. J. Nanosci. Nanotechnol. 2012, 12:2149-2159.
29. Li C.H., Shen C.C., Cheng Y.W., Huang S.H., Wu C.C., Kao C.C., Liao J.W., Kang J.J. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012, 6:746-756.
30. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
31. Chen J., Dong X., Zhao J., Tang G. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J. Appl. Toxicol. 2009, 29:330-337.
32. Hartmann A., Speit G. Genotoxic effects of chemicals in the single cell gel (SCG) test with human blood cells in relation to the induction of sister-chromatid exchanges (SCE). Mutat. Res. 1995, 346:49-56.
33. Trouiller B., Reliene R., Westbrook A., Solaimani P., Schiestl R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 15:8784-8789.
34. Singh N., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., Wright C.J., Doak S.H. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
35. Zhang S., Zhou Z., Fu J. Effect of manganese chloride exposure on liver and brain mitochondria function in rats. Environ. Res. 2003, 93:149-157.
36. Gerber G.B., Leonard A., Hantson P. Carcinogenicity, mutagenicity and teratogenicity of manganese compounds. Crit. Rev. Oncol. Hematol. 2002, 42:25-34.
37. Wang Z., Zhao J., Li F., Gao D., Xing B. Adsorption and inhibition of acetylcholinestrase by different nanoparticles. Chemosphere 2009, 77:67-73.
38. Santos D., Milatovic D., Andrade V., Batoreu M.C., Aschner M., dos Santos A.P.M. The inhibitory effect of manganese on acetylcholinestrase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology 2012, 292:90-98.
39. 2+-ATPase: modulation by l-cysteine. Basic Clin. Pharmacol. Toxicol. 2008, 103:171-175.
40. Schroeter J.D., Dorman D.C., Yoon M., Nong A., Taylor M.D., Andersen M.E., Clewell H.J. Application of multi-route physiologically based pharmacokinetic model for manganese to evaluate dose dependent neurological effects in monkeys. Toxicol. Sci. 2012, 129:432-446.
41. Schrand A.M., Rahman M.F., Hussain S.M., Schlager J.J., Smith D.A., Ali S.F. Metal based nanoparticles and their toxicity assessment. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2:544-568.
42. Conrad M.E., Umbreit J.N., Moore E.G., Hainsworth L.N., Porubcin M., Simovich M.J., Nakada M.T., Dolan K., Garrick M.D. Separate pathways for cellular uptake of ferric and ferrous iron. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G767-G774.
43. Crossgrove J.S., Yokel R.A. Manganese distribution across the blood-brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 2004, 25:451-460.
44. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
45. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
46. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., Oberdörster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 2006, 114:1172-1178.